Jimbo T - Search Results

1

Systemic administration of a synthetic lipid A derivative, DT-5461a, reduces tumor blood flow through endogenous TNF production in hepatic cancer model of VX2 carcinoma in rabbits.

Jimbo T, Akimoto T, Tohgo A. Jimbo T, et al. Anticancer Res. 1996 Jan-Feb;16(1):359-64. Anticancer Res. 1996. PMID: 8615636

2

DT-5461a, an antitumor synthetic lipid a analog, causes selective blood flow reduction in tumor tissue.

Akimoto T, Kumazawa E, Jimbo T, Joto N, Tohgo A. Akimoto T, et al. Among authors: jimbo t. Anticancer Res. 1995 Jan-Feb;15(1):105-7. Anticancer Res. 1995. PMID: 7537483

3

Intratumoral production of tumor necrosis factor augmented by endogenous interferons results in potent antitumor effects of DT-5461, a synthetic lipid A analog.

Kumazawa E, Akimoto T, Kita Y, Jimbo T, Joto N, Tohgo A. Kumazawa E, et al. Among authors: jimbo t. J Immunother Emphasis Tumor Immunol. 1995 Apr;17(3):141-50. doi: 10.1097/00002371-199504000-00003. J Immunother Emphasis Tumor Immunol. 1995. PMID: 7542128

4

Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice.

Jimbo T, Akimoto T, Tohgo A. Jimbo T, et al. Cancer Immunol Immunother. 1995 Jan;40(1):10-6. doi: 10.1007/BF01517230. Cancer Immunol Immunother. 1995. PMID: 7828163 Free PMC article.

5

Antitumor effect of DT-5461a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation.

Akimoto T, Kumazawa E, Jimbo T, Joto N, Tohgo A. Akimoto T, et al. Among authors: jimbo t. Int J Immunopharmacol. 1994 Nov;16(11):887-93. doi: 10.1016/0192-0561(94)90043-4. Int J Immunopharmacol. 1994. PMID: 7868293

6

Antitumor effect of DT-5461, a lipid A derivative, against human tumor xenografts is mediated by intratumoral production of tumor necrosis factor and affected by host immunosuppressive factors in nude mice.

Kumazawa E, Jimbo T, Akimoto T, Joto N, Tohgo A. Kumazawa E, et al. Among authors: jimbo t. Cancer Invest. 1997;15(6):522-30. doi: 10.3109/07357909709047593. Cancer Invest. 1997. PMID: 9412657

7

Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.

Kumazawa E, Jimbo T, Ochi Y, Tohgo A. Kumazawa E, et al. Among authors: jimbo t. Cancer Chemother Pharmacol. 1998;42(3):210-20. doi: 10.1007/s002800050807. Cancer Chemother Pharmacol. 1998. PMID: 9685056

8

DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo.

Shionoya M, Jimbo T, Kitagawa M, Soga T, Tohgo A. Shionoya M, et al. Among authors: jimbo t. Cancer Sci. 2003 May;94(5):459-66. doi: 10.1111/j.1349-7006.2003.tb01465.x. Cancer Sci. 2003. PMID: 12824894 Free PMC article.

9

New highly active taxoids from 9 beta-dihydrobaccatin-9,10-acetals. Part 5.

Takeda Y, Uoto K, Iwahana M, Jimbo T, Nagata M, Atsumi R, Ono C, Tanaka N, Terasawa H, Soga T. Takeda Y, et al. Among authors: jimbo t. Bioorg Med Chem Lett. 2004 Jun 21;14(12):3209-15. doi: 10.1016/j.bmcl.2004.03.109. Bioorg Med Chem Lett. 2004. PMID: 15149677

10

Orally active docetaxel analogue: synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues.

Iimura S, Uoto K, Ohsuki S, Chiba J, Yoshino T, Iwahana M, Jimbo T, Terasawa H, Soga T. Iimura S, et al. Among authors: jimbo t. Bioorg Med Chem Lett. 2001 Feb 12;11(3):407-10. doi: 10.1016/s0960-894x(00)00682-x. Bioorg Med Chem Lett. 2001. PMID: 11212122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters